$0.06
$0.00 (0.00%)
End-of-day quote: 03/11/2024
OTCPK:BLCM
Bellicum Pharmaceuticals Annual Report
| Year | Year | 2022 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.50M | $7.14M | $1.12M | $0.19M | $0.39M | $0.28M | $1.78M | |
| GM % | Gross Margin % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| EPS | Earnings Per Share |
|
$0.00 | $-0.81 | $-24.01 | $-24.40 | $-28.38 | $-25.70 | $-18.40 | $-71.00 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | -0.00% | |
| Sha. | Shares |
|
8.61m | 5.01m | 4.36m | 3.33m | 2.72m | 2.69m | 2.64m | |
| OCF | Operating Cash Flow |
|
$-25.78M | $-77.57M | $-74.78M | $-72.98M | $-50.44M | $-35.73M | $-57.31M | |
| FCF | Free Cash Flow |
|
$-25.80M | $-78.09M | $-76.40M | $-85.12M | $-57.66M | $-41.15M | $-58.11M | |
| FCFS | Free Cash Flow Per Share |
|
$-0.84 | $-16.67 | $-18.99 | $-26.84 | $-21.39 | $-15.62 | $-232.24 |
